Search in our News Channels PipelineReview.com (press release) The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II trial analyzing the combination of lenalidomide and rituximab. Celgene Reports Results From EMERGE Study On REVLIMID - Quick Facts |
